(Q51102784)

29 March 2018

title

A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety. (English)

1 reference

29 March 2018

author

Guy Griebel

series ordinal

1

1 reference

29 March 2018

author name string

G Perrault

series ordinal

2

1 reference

29 March 2018

D J Sanger

series ordinal

3

1 reference

29 March 2018

publication date

1 June 1997

1 reference

29 March 2018

published in

Neuropharmacology

1 reference

29 March 2018

volume

36

1 reference

29 March 2018

issue

6

1 reference

29 March 2018

page(s)

793-802

1 reference

29 March 2018

Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

5-HT2 receptor subtypes: a family re-united?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Novel discriminatory ligands for 5-HT2B receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

PD135158, a CCK-B antagonist, reduces "state," but not "trait" anxiety in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Serotonin function in anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Actions of buspirone in a putative model of anxiety in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: A Novel 5-HT2C/5-HT2B Receptor Antagonist with Improved Affinity, Selectivity, and Oral Activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Effects of acute and subchronic administration of ritanserin on the social behaviour of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Anxiolytic-like effects of a selective 5-HT1A agonist, S20244, and its enantiomers in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Further evidence for differences between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Anxiolytic activity of adenosine receptor activation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Behavioral indications for serotonin receptor hypersensitivity in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

The use of a plus-maze to measure anxiety in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

New mouse 5-HT2-like receptor. Expression in brain, heart and intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Behavioural Validation of a Light/Dark Choice Procedure for Testing Anti-Anxiety Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Anxiolytic and sedative effects of 5-HT1A ligands, 8-OH-DPAT and MDL 73005EF, in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Behavioral profile of the 5HT1A receptor antagonist (S)-UH-301 in rodents and monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Animal models for the study of anti-anxiety agents: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

A simple and reliable conflict procedure for testing anti-anxiety agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Serotonin-influencing drugs in the treatment of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Anxiolytic and sedative properties of BW A78U, a novel anticonvulsant adenine derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2897%2900034-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0028-3908(97)00034-8

1 reference

29 March 2018

1 reference

29 March 2018